Human immunodeficiency virus type 1 pharmacogenomics in clinical practice: relevance of HIV-1 drug resistance testing (Part 1).
Patarca R, Isava A, Campo R, Rodriguez NJ, Nunez E, Alter M, Marchette M, Sanabia MM, Mitchell C, Rivera D, Scott G, Jayaweera D, Moreno J, Boulanger C, Kolber M, Mask CW, Sierra EM, Vallejo R, Page JB, Klimas NG, Fletcher MA.
Patarca R, et al. Among authors: klimas ng.
J Environ Pathol Toxicol Oncol. 2003;22(3):201-34. doi: 10.1615/jenvpathtoxoncol.v22.i3.40.
J Environ Pathol Toxicol Oncol. 2003.
PMID: 14529094
Review.